American College of Rheumatology 2014 Annual Meeting

American College of Rheumatology 2014 Annual Meeting | ACR 2014

The ACR 2014 Annual Meeting will "showcase cutting-edge and timely topics in clinical and basic science of rheumatologic care, as well as the prevention, diagnosis, and treatment of rheumatic diseases and its comorbid conditions."

Conference Coverages

Intra-articular Injection of Traumeel and Zeel Reduce Knee Pain in Double-blind Trial
Intra-articular Injection of Traumeel and Zeel Reduce Knee Pain in Double-blind Trial
Intra-articular injection of two widely used plant and mineral extract-based formulations provide long-lasting pain relief in patients with moderate to severe pain from knee osteoarthritis, according to the first-ever double-blind trial of the treatments.
HD203 Biosimilar is Clinically Equivalent to Etanercept
A "biosimilar" form of etanercept is clinically equivalent to the branded form for rheumatoid arthritis, according to data presented at the 2014 annual meeting of the American College of Rheumatology.
Baseline Interferon Ratio Predicts Response to anti-TNF Therapy
A blood test may offer a reliable way to identify rheumatoid arthritis patients who are unlikely to respond to anti-tumor necrosis factor-alpha inhibitors, speeding treatment with other drugs and lowering costs.
Women Using IUDs at Greater Risk for Rheumatoid Arthritis
Women using intrauterine devices with a family history of rheumatoid arthritis are at greater risk for the condition.
No Increase in Knee Osteoarthritis from Running
Running does not increase the risk for knee osteoarthritis (OA), according to study results presented at the 2014 annual meeting of the American College of Rheumatology. No increase in knee OA or knee pain was associated with habitual running in any age group in a study of over 600 individuals who reported running as a regular activity at some point in their lives.
Zoster Vaccination in Patients with Rheumatoid Arthritis: Time to Change the Recommendation?
Administration of the varicella zoster vaccine is safe in patients with rheumatoid arthritis or other rheumatic conditions who are taking biologic disease-modifying anti-rheumatic drugs, according to study results presented at the 2014 American College of Rheumatology annual meeting.
Treating to Target Reduces Rheumatoid Arthritis Mortality
Adjusting treatment to maintain tight control of disease-related disability reduces mortality in rheumatoid arthritis, according to new research presented at the 2014 American College of Rheumatology annual meeting.
Secukinumab Effective for Treatment-Resistant Ankylosing Spondylitis
A Phase 3 trial of the monoclonal antibody secukinumab indicates it is an effective treatment for patients with ankylosing spondylitis (AS) incompletely treated by standard therapy, according to data presented at the 2014 American College of Rheumatology meeting.
Hydroxychloroquine Reduces Risk of Cardiovascular Events in Rheumatoid Arthritis
The anti-arthritis drug hydroxychloroquine dramatically reduces the risk of cardiovascular morbidity and mortality in the disease, according to research presented here at the 2014 meeting of the American College of Rheumatology.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$